12th October 2023

PharmaLex newsletter: Autumn 2023

Twitter: @pharmasol
LinkedIn: https://www.linkedin.com/company/pharmasol

- Corporate Update
- New Podcast
- Customer Success
- Product Spotlight
- Event Review

CORPORATE UPDATE: Where expertise meets innovation

Tim Billington, Commercial Director of PV Digital Solutions, shares the PharmaLex vision behind the integrated capabilities now available to customers.

When excellence intersects across disciplines, big leaps in capability are possible. At PharmaLex, this integration of best-in-class services with leading technology is foundational to our customer offer. We call this “where expertise meets innovation”.

Innovation is truly in our DNA, and with advanced software and technology-elevated services now working together under our Digital Innovation strategy umbrella, we think PharmaLex is uniquely positioned to help our customers improve compliance, boost the quality of PV operations, and speed time to market.

Within our group, hundreds of experts across our technology and digital services team – from data specialists to IT strategy consultants – are actively collaborating to support our internal platforms and drive development of our SaaS solutions. It’s what differentiates our approach to innovation, and what ultimately drives our vision of revolutionising the life sciences industry – working collaboratively to identity and create transformative opportunities, and developing new ideas and applications based on state-of-the-art technology.

The sheer breadth and deep of core life sciences expertise that we hold in our global team, coupled with our innovative technologies, is delivering elevated business value to our customers today across the industry, wherever they are in the world. We’re committed to making this visible difference, and we hope that you’ll continue to let us know when we succeed.

Meet the PharmaLex management team:
Sébastien Schmitt, Chief Commercial Officer

Bringing over 20 years’ experience in sales, marketing and delivery, with a solid track record in providing tailored service solutions to multi-national clients, Sébastien Schmitt serves at Chief Commercial Officer for PharmaLex Group.

““PharmaLex has shown exceptional leadership in delivering end-to-end product commercialization solutions that span the entire pharma value chain – from discovery to market access. Our experienced global team, with their technical excellence and rich understanding of pharmaceutical lifecycle processes, are highly skilled at drawing together innovative services and technology-elevated solutions to support clients wherever they are in the product lifecycle.

Our unique combination of multidisciplinary expertise and cutting-edge technology-enabled services is enabling us to streamline time-to-market and speed time-to-revenue for clients across the world.”

LISTEN NOW: NEW PODCAST – SCALING PATIENT SAFETY THROUGH INNOVATION

NEW: We’ve very excited to be bringing you this fantastic edition of the ‘PharmaLex Talks’ podcast, ‘Scaling Patient Safety Through Innovation’.

We’ve brought together two leading experts – Cheryl James, Director of Safety Analytics at PharmaLex, and Michael Braun-Boghos, Senior Director of Safety Strategy at Oracle – to discuss the evolution of PV through the decades, and share their views on where innovation needs to focus in the future to ensure that the PV function continues to meet critical needs and also add value.

Cheryl and Michael bring their considerable expertise to bear on how new technology can help life science organisations effectively scale their PV functions to address the continuous rise in adverse event reporting volumes, plus navigate the ever-increasing regulatory requirements and the addition of new data streams.

It’s a fascinating topic, and an illuminating discussion. Listen to it online now.

CELEBRATING CUSTOMER SUCCESS

Recent rapidLIVE wins

• Since our last newsletter, our onboarding team has been busy rolling out our rapidLIVE accelerated deployment solution for Oracle Argus Safety for a raft of new customers. In a highlight project, we have been engaged by a CRO in Italy looking to migrate its entire portfolio of sponsors over to Argus. With the integration almost complete, the rapidLIVE solution is due to go live at the end of this month for our CRO’s first sponsor tenant, closely followed by a further five.
• In parallel, we have also been planning and implementing a 3000+ safety case migration for a major biotech company in the Netherlands. As part of the deployment, we delivered our first on-site training since COVID, which has helped to accelerate ramp-up for our customer. We look forward to a seamless production migration of 3000+ cases from two source systems by October!
• In other exciting developments, our rapidLIVE team has been working on a series of reporting configuration enhancements and product fixes that have now passed validation, so will be rolling out these improvements to our SaaS customer in the coming months.
• Finally, with the release of Argus Safety version 8.4.1 in recent weeks, we’re now hard at work planning the next major upgrade to rapidLIVE Oracle Argus. Do watch this space!

Highlight psiXchange win

• A leading global CRO will be completing its validation of psiXchange in the coming weeks and will be live in Q4 with the latest system release. Another great win for PharmaLex, and for our customer!
• Hot off the press, another leading global CRO signed for psiXchange in September and will be starting the project in Q4 this year…